Ordesekimab
奥司奇单抗
Report date: 2022/07/04 19:38:02
Base Information
Drug NameOrdesekimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenmab A/SProvention Bio IncAmgen Inc
China Registration ClassN/A
Develop Information
Active CompaniesProvention Bio IncAmgen IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A